Munich Re and Marsh & McLennan Cos. introduced a product to insure U.S. pharmaceutical companies against regulatory actions that could cause them to suspend manufacturing.
Chris Smy & co. are securing clients by changing the dialogue around the P word and focusing on operational riskand having an in-house environmental-consulting firm doesnt hurt.
Willis Chairman and CEO Joe Plumeri sees "smaller, localized waves" replacing the the "rising tide that lifts all boats" when it comes to the insurance-pricing cycle. Willis sees a leveling off in commercial-property pricing in 2013, while casualty risks will likely see more increases.